29 patents currently held
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2030. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
5
Ending by 2030
Mar 2030
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2032 · High confidence
Also notable
Ends Nov 2035 · Medium confidence
Also notable
Ends Jan 2039 · High confidence
Also notable
Ends Mar 2039 · High confidence
Also notable
Ends Jan 2039 · High confidence
Also notable
Ends Jul 2039 · High confidence
Also notable
Ends Mar 2039 · High confidence
Also notable
Ends Mar 2039 · High confidence
Devices and Methods for Delivery of Aortic and Mitral Valve Prostheses
US 8,540,767
Cited by 418 later US patents, top 1% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
Heart Valve Prosthesis
US 11,406,497
Cited by 41 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2035.
Heart Valve Prosthesis
US 11,253,363
Cited by 17 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2039.
Prosthetic Heart Valve Delivery System
US 11,020,226
Cited by 36 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2039.
Heart Valve Prosthesis Delivery System
US 11,357,626
Cited by 14 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2039.
Heart Valve Prosthesis
US 11,083,577
Cited by 18 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2039.
Methods and Devices for Delivery of a Prosthetic Valve
US 11,331,184
Cited by 14 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2039. A terminal disclaimer caps this term to an earlier patent's.
Heart Valve Prosthesis Delivery System
US 11,090,156
Cited by 13 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 21, 2027The maintenance fee for Heart Valve Prosthesis Delivery System (US 11,819,407) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for Methods and Devices for Delivery of a Prosthetic Valve (US 11,938,024) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Devices and Methods for Delivery of Aortic and Mitral Valve Prostheses | 5 in force | to Apr 2032 |
| Heart Valve Prosthesis (2019) | 3 in force | to Jan 2042 |
| Heart Valve Prosthesis (2019) | 3 in force | to Nov 2039 |
| Heart Valve Prosthesis (2019) | 3 in force | to Nov 2035 |
| Prosthetic Heart Valve | 2 in force | to Mar 2041 |
| Methods and Devices for Delivery of a Prosthetic Valve | 2 in force | to Nov 2039 |
| Heart Valve Prosthesis Delivery System (2019) | 2 in force | to Sep 2039 |
| Crimper Device | 2 in force | to Jan 2037 |
| Heart Valve Prosthesis Delivery System (2019) | 1 in force | to Mar 2039 |
| Prosthetic Heart Valve Delivery System | 1 in force | to Mar 2039 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,907,650 | Devices and Methods for Delivery of Valve Prostheses In force · High confidence | In force | High confidence | |
| US 11,045,316 | Devices and Methods for Delivery of Valve Prostheses In force · High confidence | In force | High confidence | |
| US 10,743,987 | Devices and Methods for Delivery of Valve Prostheses In force · High confidence | In force | High confidence | |
| US 11,589,984 | Devices and Methods for Delivery of Valve Prostheses In force · High confidence | In force | High confidence | |
| US 8,366,767 | Methods and Devices for Transapical Delivery of a Sutureless Valve Prosthesis In force · High confidence | In force | High confidence | |
| US 8,366,768 | Methods for Delivery of a Sutureless Pulmonary or Mitral Valve In force · High confidence | In force | High confidence | |
| US 8,444,689 | Valve Prosthesis with Movably Attached Claspers with Apex In force · High confidence | In force | High confidence | |
| US 8,540,767 | Devices and Methods for Delivery of Aortic and Mitral Valve Prostheses In force · High confidence | In force | High confidence | |
| US 11,938,024 | Methods and Devices for Delivery of a Prosthetic Valve In force · Medium confidence | In force | Medium confidence | |
| US 11,259,923 | Methods and Devices for Delivery of a Prosthetic Valve In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 29: 6 patents in force now held by others · 15 applications pending. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.